The Femtech & Women’s Health edition of ‘Discovery Spark’ champions early stage businesses working to close the gender health gap
Sandwich, Kent, UK / 30th May 2024 / Discovery Park, Kent’s thriving life science and innovation community, announced the selection of 11 promising start-ups in FemTech & Women’s Health to join Discovery Spark, their growth and support programme for early stage businesses.
Igniting the growth of businesses solving women’s health challenges, the special female-focused edition of the Discovery Spark programme offers tailored mentoring and support…
Read June's eNews
Featuring:
Tony Jones intro direct from the BIO International Convention
Welcome to a Golden Age of ADCs (Plus More!)
Exploring the Evolving Landscape of Cell and Gene Therapy Dealmaking
Being A Superpower – Is It All About Science?
UK, Minnesota, North Carolina Top Trumps!
Building Life Science Adventures News
Sponsored by JMP - Accelerate Innovation with Design of Experiments (DOE) Webinar
Stay ahead with the latest in life science!
Three-storey, multi-occupancy building on track to provide fully fitted laboratory suites for fast-growing life science community within the Cambridge cluster
Cambridge, UK, 5th June 2024: Chesterford Research Park has announced the appointment of Glencar to undertake construction of its new Sidney Sussex Building, which is expected to deliver over 60,000 sq ft of laboratory and office space.
Owned by Aviva Investors, the global asset management business of Aviva plc, alongside Uttlesford District Council, Chesterford Research Park provides 250 acres of advanced laboratory and office space…
Bruntwood SciTech is announcing the launch of its new Life Science Accelerator programme at Alderley Park in a move aimed at supporting even greater innovation and economic growth in the region.
The new Life Science Accelerator has been designed to cater to the unique needs of early stage life science companies from across the UK, offering comprehensive support and specialist facilities to fuel their growth and development. Alderley Park, owned and operated by Bruntwood SciTech – a joint venture between Bruntwood, Legal & General and Greater Manchester Pension Fund – is…
Cambridge, 30th May 2024: Six life science start-ups looking to develop products and services to make a positive difference to healthcare have been selected for one of Europe’s top incubators based at the Babraham Research Campus in Cambridge – Accelerate@Babraham.
The package of support on offer which includes a year’s free lab space, £10k funding and access to an unrivalled network of experts, mentors and investors is always hotly contested and this year was no exception with the selection panel impressed by the strength of extremely high-quality applications.
Introducing the 2024 cohort…
Tokyo, Japan, Oxford and Cambridge, UK, 30 May 2024 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) and PrecisionLife, the Causal AI precision medicine company, today announce the expansion of their strategic R&D partnership into auto-immune disorders with the potential to identify new drug targets for the treatment of complex, chronic conditions.
This is the latest in a series of collaborative agreements between Nxera and PrecisionLife, which began in 2022. The partnership aims to establish new drug targets and subsequently potential precision targeted therapies for auto-immune disorders,…
RNA sequencing is becoming the gold-standard method for uncovering the cellular mechanisms behind disease. A variety of RNA sequencing techniques have evolved, which provide all-important information on disease causes and progression for more effective treatments.
Read our latest blog here:
https://sourcebioscience.com/comparing-rna-sequencing-techniques/
Source LDPath is a flexible and trusted extension to your histopathology laboratory, supporting you to accelerate turnaround times for reporting and decrease backlogs.
In 2023, we successfully reported over 260,000 cases with our NHS histopathology partners, and we are delighted to announce that we have further increased our capacity this year to support your department and provide better patient care.
We have capacity to support:
Pre-prepared Slides
Wet Surgical Specimens
Block to Slide
Wets to Slide
Block to Report
Reporting - Traditional and Digital
Source LDPath provides end-to-end…
We are delighted to announce that our latest whitepaper, written in collaboration with Deloitte: 'Australian R&D Cashback and Early Development Activities', is now available to read and download.
This whitepaper explores the Australian government's initiatives designed to help drug developers swiftly advance their products into early-phase clinical trials, while also benefiting from R&D tax incentives. With streamlined processes, cost efficiencies, a simplified regulatory framework, and a high-quality healthcare sector, Australia is a global competitive destination for…
GMP compliant materials and support for ATMP manufacturing.
AMSBIO is dedicated to helping its customers seamlessly translate their cutting-edge research into production products for clinical therapy. A comprehensive new resource has been added to the website, where you will find links to all the information you need on how AMSBIO can help you better understand and set up a GMP manufacturing process.
In addition to a complete list of GMP compliant products and services, the new section includes an informative ‘Guide to GMP,’ a GMP reference area, and a link to AMSBIO…